Transparency Market Research has published a new report titled "In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018" to its report store.

Albany, NY -- (SBWire) -- 06/08/2015 --In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 – 2018, keeping 2011 as the base year. The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report.

The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million.

For more information, Tables, figures and Segmentation, visit:
http://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

This report includes the market shares of key players in 2011. Moreover, company profiles for some of the key players are included in the report in terms of company overview, financial overview, business strategies, recent developments and product portfolio. The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.

Requesting Smaple : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1395

The global in vitro diagnostics market is categorized into the following segments:

Market by Products
- U.S.
- Clinical Chemistry
- Immunoassay
- Diabetes Testing
- Blood Testing
- Molecular Diagnostics
- Others (Flow Cytometry, Microbiological Diagnostic Techniques)
- India
- Clinical Chemistry
- Immunoassay
- Diabetes Testing
- Blood Testing
- Molecular Diagnostics
- Others (Flow Cytometry, Microbiological Diagnostic Techniques)
- China
- Clinical Chemistry
- Immunoassay
- Diabetes Testing
- Blood Testing
- Molecular Diagnostics
- Others (Flow Cytometry, Microbiological Diagnostic Techniques)

Market by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)

About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.